US 8119769
Complement depletion using recombinant human C-3 derivatives
granted A61KA61K38/00A61P
Quick answer
US patent 8119769 (Complement depletion using recombinant human C-3 derivatives) held by PLS-Design GmbH expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PLS-Design GmbH
- Grant date
- Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P11/06